TSPAN8-LEL recognized antibody shows inhibition of ovarian cancer cell metastasis both ex vivo and in vivo without severe in vitro cytotoxicity or in vivo nephrotoxicity and hepatotoxicity (92). Here, TSPAN8 is linked to ovarian cancer.